Recombinant human endostatin plus paclitaxel/nedaplatin for recurrent or metastatic advanced esophageal squamous cell carcinoma: a prospective, single-arm, open-label, phase II study

Investigational New Drugs ◽

10.1007/s10637-020-01021-1 ◽

2020 ◽

Author(s):

Zhi-Qiang Wang ◽

De-Shen Wang ◽

Feng-Hua Wang ◽

Chao Ren ◽

Qiong Tan ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Recombinant Human Endostatin ◽

Open Label Phase

Download Full-text

Randomized phase II study of recombinant human endostatin combined with definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.4035 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 4035-4035 ◽

Author(s):

Jiahua Lv ◽

Tao Li ◽

Xiaorong Deng ◽

Fang Li ◽

Yanqiong Song ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Locally Advanced ◽

Definitive Chemoradiotherapy ◽

Recombinant Human Endostatin ◽

Randomized Phase Ii

Download Full-text

Toxicity of Cetuximab, Paclitaxel, Cisplatin and Concurrent Radiation in Chinese Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: An Open-label, Multicenter Phase II Study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2011.06.512 ◽

2011 ◽

Vol 81 (2) ◽

pp. S315-S316

Author(s):

J. Yu ◽

J. Wang ◽

X. Sun ◽

L. Wang ◽

M. Ye ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Locally Advanced ◽

Chinese Patients ◽

Multicenter Phase

Download Full-text

Single-arm, Open-label, Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Case Medical Research ◽

10.31525/ct1-nct03917966 ◽

2019 ◽

Author(s):

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Preoperative Chemotherapy ◽

Squamous Cell ◽

Phase Ii Trial ◽

Locally Advanced ◽

Open Label Phase

Download Full-text

A Randomized, Open-Label, Phase II Study of Afatinib Versus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Annals of Oncology ◽

10.1016/s0923-7534(20)32015-9 ◽

2012 ◽

Vol 23 ◽

pp. xi35 ◽

Author(s):

T.Y. Seiwert ◽

J. Fayette ◽

D. Cupissol ◽

J.M. DelCampo ◽

P.M. Clement ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Neck Squamous Cell Carcinoma ◽

Open Label Phase

Download Full-text

1094TiP A randomized, controlled, open-label, phase II study of cemiplimab as a single agent and in combination with RP1 in patients with advanced cutaneous squamous cell carcinoma [CERPASS]

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1479 ◽

2021 ◽

Vol 32 ◽

pp. S904

Author(s):

A.M. Haydon ◽

M. Alamgeer ◽

D. Brungs ◽

F. Collichio ◽

N.I. Khushalani ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Single Agent ◽

Cutaneous Squamous Cell Carcinoma ◽

Randomized Controlled ◽

Open Label Phase

Download Full-text

1448P Paclitaxel and cisplatin combined with anlotinib as first line regimen for advanced esophageal squamous cell carcinoma (ESCC): A single-arm, multicentre open-label phase II clinical trial

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1954 ◽

2020 ◽

Vol 31 ◽

pp. S910-S911

Author(s):

J-S. Wang ◽

T. Wu ◽

Y-G. Hong ◽

Y-Z. Guo ◽

S-X. Luo ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Clinical Trial ◽

Open Label Phase

Download Full-text

Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: Preliminary results of a phase II study

10.18632/oncotarget.5193 ◽

2015 ◽

Vol 6 (35) ◽

pp. 38429-38439 ◽

Author(s):

Yaping Xu ◽

Yuanda Zheng ◽

Xiaojiang Sun ◽

Xinmin Yu ◽

Jialei Gu ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Elderly Patients ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Preliminary Results ◽

Concurrent Radiotherapy

Download Full-text

A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-007-0577-6 ◽

2007 ◽

Vol 62 (1) ◽

pp. 77-84 ◽

Author(s):

Jeeyun Lee ◽

Young-Hyuck Im ◽

Eun Yoon Cho ◽

Yong Sang Hong ◽

Hyo Rak Lee ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Line Chemotherapy

Download Full-text

A randomized phase II study of leucovorin, 5-fluorouracil with or without oxaliplatin (LV5FU2 vs. FOLFOX) for curatively-resected, node-positive esophageal squamous cell carcinoma

Annals of Oncology ◽

10.1093/annonc/mdw371.35 ◽

2016 ◽

Vol 27 ◽

pp. vi218

Author(s):

S.H. Lim ◽

Y.-L. Choi ◽

S.-H. Jung ◽

M.-J.A. Ahn ◽

K. Park ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Node Positive ◽

Randomized Phase Ii ◽

Download Full-text

Nal-iri/lv5-fu versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI-PRODIGE 62): A FFCD multicenter, randomized, phase II study

Annals of Oncology ◽

10.1093/annonc/mdz247.168 ◽

2019 ◽

Vol 30 ◽

pp. v324

Author(s):

V. Randrian ◽

A. Adenis ◽

J. Desrame ◽

E. Barbier ◽

F. Di Fiore ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Second Line ◽

Second Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text